APT Medical Inc.
688617
Rank in Stocks
#3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Share Price
$38.62
Market Cap
$5.47B
Change (1 day)
0.19%
Change (1 year)
-17.07%
Country
CN
Trade APT Medical Inc. (688617)
Category
Healthcare
Revenue for APT Medical Inc. (688617)
Revenue in Jun 2026 TTM: $433.73M
According to APT Medical Inc. latest financial reports the company's current revenue (TTM) is $433.73M. In 2024 the company made a revenue of $283.02M an increase over the revenue in the year 2023 that was $233.13M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for APT Medical Inc. from 2017 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $433.73M | 17.44% |
| 2025 | $369.32M | 30.49% |
| 2024 | $283.02M | 21.40% |
| 2023 | $233.13M | 32.24% |
| 2022 | $176.29M | 35.21% |
| 2021 | $130.38M | 77.65% |
| 2020 | $73.39M | 26.51% |
| 2019 | $58.01M | 65.05% |
| 2018 | $35.15M | 49.30% |
| 2017 | $23.54M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $48.23B | 11,019.58% |
US
|
|
| $37.54B | 8,555.60% |
IE
|
|
| $25.84B | 5,856.92% |
US
|
|
| $21.00B | 4,740.79% |
US
|
|
| - | - |
DE
|
